The muscle mitogen-activated protein kinase is altered in sporadic inclusion body myositis

Neurology

Volumn 54, Issue 8, 2000, Pages 1665-1669

  Li, Mian ^a   Dalakas, Marinos C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Muscle mitogen activated protein kinase; Sporadic inclusion body myositis

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME ANALYSIS; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCLUSION BODY MYOSITIS; MUSCLE BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 0034008750     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.8.1665     Document Type: Article

References (29)

1. Dalakas MC. Immunopathogenesis of inflammatory myopathies. In: Antel JP, Birnbaum G, Hartung HP, eds. Clinical neuroimmunology. Cambridge, MA: Blackwell Science, 1998: 374-384.
2. Sekul EA, Dalakas MC. Inclusion body myositis: new concepts. Semin Neurol 1993;13:256-263.
3. Karpati G, Carpenter S. Pathology of the inflammatory myopathies. Baillieres Clin Neurol 1993;2:527-556.
4. Askanas V, Engel WK, Bilak M, Alvarez RB, Selkoe DJ. Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am J Pathol 1994;144: 177-187.
5. Mikol J, Engel AG. Inclusion body myositis. In: Engel AG, Franzini-Armstrong C, eds. Myology 1994:1384-1398.
6. Yunis EJ, Samaha FJ. Inclusion body myositis. Lab Invest 1971;25:240-248.
7. Askanas V, Engel WK. Sporadic inclusion body myositis and hereditary inclusion body myopathies: diseases of oxidative stress and aging? Arch Neurol 1998;55:915-920.
8. Tohtong R, Yamashita H, Graham M, Haeberle J, Simcox A, Maughan D. Impairment of muscle function caused by mutations of phosphorylation sites in myosin regulatory light chain. Nature 1995;374:650-653.
9. Poetter K, Jiang H, Hassanzadeh S, et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 1996;13:63-69.
10. Doroudchi MM, Durham HD. Activation of protein kinase c induces neurofilament fragmentation, hyperphosphorylation of perikaryal neurofilaments and proximal dendritic swellings in cultured motor neurons. J Neuropathol Exp Neurol 1996; 55:246-256.
11. Nakano S, Engel AG, Akiguchi I, Kimura J. Myofibrillar myopathy. III. Abnormal expression of cyclin-dependent kinases and nuclear proteins. J Neuropathol Exp Neurol 1997;56: 850-856.
12. Boulton TG, Nye SH, Robbins DJ, et al. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 1991;65:663-675.
13. Reszka AA, Seger R, Diltz CD, Krebs EG, Fischer EH. Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci USA 1995;92:8881-8885.
14. Bennett AM, Tonks NK. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 1997;278:1288-1291.
15. Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K. Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study. Neurology 1997;48: 712-716.
16. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990;322:1098-1105.
17. Cupler EJ, Leon-Monzon M, Miller J, Semino-Mora C, Anderson TL, Dalakas MC. Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain 1996;119:1887-1893.
18. Chen W, Martindale JL, Holbrook NJ, Liu Y. Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc. Mol Cell Biol 1998;18:5178-5188.
19. Nicholson LV, Davison K, Johnson MA, et al. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci 1989;94:137-146.
20. Hoshi M, Ohta K, Gotoh Y, et al. Mitogen-activated-protein-kinase-catalyzed phosphorylation of microtubule-associated proteins, microtubule-associated protein 2 and microtubule-associated protein 4, induces an alteration in their function. Eur J Biochem 1992;203:43-52.
21. Toyama Y, Forry-Schaudies S, Hoffman B, Holtzer H. Effects of taxol and colcemid on myofibrillogenesis. Proc Natl Acad Sci USA 1982;79:6556-6560.
22. Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski MA, Peper M. Colchicine myopathy and neuropathy. N Engl J Med 1987;316:1562-1568.
23. Dalakas MC. Molecular immunology and genetics of inflammatory muscle diseases. Arch Neurol 1998;54:1509-1512.
24. Reimann T, Hempel U, Krautwald S, et al. Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett 1997;403: 57-60.
25. Greenberg SM, Koo EH, Selkoe DJ, Qiu WQ, Kosik KS. Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc Natl Acad Sci USA 1994;91:7104-7108.
26. Doulos JE, Weber JD, Bellezzo J, et al. Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells. AM J Physiol 1997; 273:G804-811.
27. Morino N, Mimura T, Hamasaki K, et al. Matrix/integrin interaction activates the mitogen-activated protein kinase, p44erk-1 and p42erk-2. J Biol Chem 1995;270:269-273.
28. Goebels N, Michaelis D, Engelhardt M, et al. Differential expression of perform in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest 1996;97:2905-2910.
29. Choi Y-C, Dalakas MC. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology 2000;54:65-71.